{"disease":{"id":"complication-of-extracorporeal-circulation","name":"complication of extracorporeal circulation"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03609723","title":"Combined Use of a Novel Cardioplegic Formula With MPS ® Using the MiECC in Isolated CABG Versus OPCABG","phase":"","overall_status":"COMPLETED","enrollment_count":2433,"lead_sponsor_name":"University Hospital, Basel, Switzerland","has_results":false},{"nct_id":"NCT03612388","title":"Combined Use of a Novel Cardioplegic Formula With Myocardial Protection System (MPS)® Versus Cardioplexol ® in Isolated Coronary Artery Bypass Grafting (CABG) Using MiECC;","phase":"","overall_status":"COMPLETED","enrollment_count":211,"lead_sponsor_name":"University Hospital, Basel, Switzerland","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}